Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 31 08 2020
revised: 09 10 2020
accepted: 10 10 2020
pubmed: 20 10 2020
medline: 14 1 2021
entrez: 19 10 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the pulmonary disease coronavirus disease 2019 (COVID-19, which has challenged health care facilities worldwide. The sustainability of health care systems is largely reliant on the health status of their health care workers (HCW). This study aimed to detect the SARS-CoV-2 virus and specific antibodies among HCWs in a German hospital as a model system for the potential spread of the pandemic. Between March and June 2020, we used a combination of RT-PCR testing to detect SARS-CoV-2 RNA and an enzyme-linked immunosorbent assay to detect the presence of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies among HCWs in a German hospital based on repetitive oropharyngeal swabs (OPSs) and blood samples. In total, 871/1081 employees participated in this prospective longitudinal study. During the study period of 9 weeks, 5329 OPSs and 2136 blood samples were analyzed. SARS-CoV-2 RNA was detected in three participants (0.34%). Anti-SARS-CoV-2 IgG antibodies were detected in 38 (4.36%) participants. Our study determined a low prevalence of COVID-19 in HCW, which may reflect the effectiveness of hygiene protocols. However, it could also indicate a low prevalence of SARS CoV-2 in hospital employees. Our study protocol may serve as an instructive example for future pandemic containment protocols in hospitals.

Identifiants

pubmed: 33075538
pii: S1201-9712(20)32230-X
doi: 10.1016/j.ijid.2020.10.026
pmc: PMC7566663
pii:
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-143

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
PLoS One. 2020 Jun 25;15(6):e0235417
pubmed: 32584894
Euro Surveill. 2020 Jul;25(28):
pubmed: 32700672
J Clin Virol. 2020 Jul;128:104413
pubmed: 32403010
N Engl J Med. 2020 Sep 10;383(11):1085-1087
pubmed: 32706954
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
BMC Infect Dis. 2020 Nov 16;20(1):853
pubmed: 33198725
Infect Dis Ther. 2020 Dec;9(4):837-849
pubmed: 32886335
Clin Microbiol Infect. 2020 Oct;26(10):1386-1394
pubmed: 32603801
J Clin Virol. 2020 Sep;130:104575
pubmed: 32805631
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347204
J Clin Virol. 2020 Jul;128:104417
pubmed: 32403007
Euro Surveill. 2020 Mar;25(12):
pubmed: 32234115
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Infect. 2020 Jun;80(6):e32-e33
pubmed: 32209383
Eur J Neurol. 2020 Sep;27(9):1794-1800
pubmed: 32492764
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290904
J Clin Virol. 2020 Jul;128:104394
pubmed: 32416599
Lancet. 2020 Mar 21;395(10228):922
pubmed: 32199474
GMS Hyg Infect Control. 2020 May 14;15:Doc09
pubmed: 32547909
Lancet Respir Med. 2020 May;8(5):506-517
pubmed: 32272080
Rev Saude Publica. 2020;54:69
pubmed: 32638883
PLoS One. 2020 May 14;15(5):e0233255
pubmed: 32407411
Infection. 2020 Aug;48(4):631-634
pubmed: 32524515
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
GMS Hyg Infect Control. 2020 Jul 23;15:Doc18
pubmed: 32733782
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Pediatr Allergy Immunol. 2020 Jul;31(5):560-564
pubmed: 32319131
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847
pubmed: 32413201
Swiss Med Wkly. 2020 Apr 25;150:w20257
pubmed: 32333603
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Jonas Herzberg (J)

Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, Hamburger Strasse 41, 21465 Reinbek, Germany. Electronic address: jonas.herzberg@Krankenhaus-Reinbek.de.

Tanja Vollmer (T)

Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany.

Bastian Fischer (B)

Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany.

Heiko Becher (H)

Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Ann-Kristin Becker (AK)

Kopf- und Neurozentrum, Asklepios Klinik Altona, Paul-Ehrlich-Strasse 1, 22763 Hamburg, Germany.

Hany Sahly (H)

Labor Lademannbogen MVZ Hamburg, Lademannbogen 61, 22339 Hamburg, Germany.

Human Honarpisheh (H)

Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, Hamburger Strasse 41, 21465 Reinbek, Germany.

Salman Yousuf Guraya (SY)

Clinical Sciences Department, College of Medicine, University of Sharjah, P. O. Box 27272 Sharjah, United Arab Emirates.

Tim Strate (T)

Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, Hamburger Strasse 41, 21465 Reinbek, Germany.

Cornelius Knabbe (C)

Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH